NeuPath Health Inc.
NPTH.V
TSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 26.77% | -0.15% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 26.77% | -0.15% | |||
| Cost of Revenue | 25.25% | 0.31% | |||
| Gross Profit | 33.34% | -2.11% | |||
| SG&A Expenses | 21.04% | -8.21% | |||
| Depreciation & Amortization | -0.26% | -0.98% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.87% | -0.99% | |||
| Operating Income | 147.38% | 53.51% | |||
| Income Before Tax | 361.98% | -32.29% | |||
| Income Tax Expenses | 15.43% | 251.14% | |||
| Earnings from Continuing Operations | 208.52% | -77.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -1.34% | -29.09% | |||
| Net Income | 164.80% | -64.46% | |||
| EBIT | 147.38% | 53.51% | |||
| EBITDA | 63.59% | 88.87% | |||
| EPS Basic | 164.71% | -64.52% | |||
| Normalized Basic EPS | 2,950.00% | 166.67% | |||
| EPS Diluted | 147.14% | -125.81% | |||
| Normalized Diluted EPS | 2,850.00% | 166.67% | |||
| Average Basic Shares Outstanding | 0.63% | -0.32% | |||
| Average Diluted Shares Outstanding | 1.69% | 1.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||